![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 09, 2010 5:23:57 PM
Life Sciences - Medical Device Patent Prosecution
Our patent prosecutors in the Medical Device Group have a wide range of prosecution experience with many types of medical devices. Examples include radiology systems (e.g., MRI, radiography, ultrasound, PET, CT), medical informatics and software, cardiology and vascular surgery (e.g., stents, electrophysiology systems for arrhythmia treatment, implantable cardioverter defibrillators), neurosurgery and neuroradiology (e.g., stereotactic surgical systems, intracranial aneurysm therapies), gastroenterology and bariatric surgery (e.g., enteric implants, gastric restriction devices for obesity), urology (e.g., cystoscopy, artificial bladders), ophthalmology (e.g., artificial vision, retinal implants, poststroke visual retraining, refractive surgical systems, macular degeneration therapy systems, contact lenses, glaucoma devices), other surgical specialties (e.g., lasers, suture systems, prosthetic limbs, orthopedic systems), psychiatry (e.g., therapeutic prediction software for affective disorders), and many others in all fields of medicine. Many of our patent prosecutors have advanced or professional degrees in electrical, biomedical or mechanical engineering, or medicine. Many are routinely involved with litigation and "build” into patent applications best practices gleaned from recent court decisions.
Our medical device team has experience not only with patent prosecution within the U.S. Patent and Trademark Office, but also with the U.S. Food and Drug Administration. We regularly provide clients with counseling on how to best achieve their goals within both federal agencies for their medical device technology. We provide corresponding services internationally through our European offices and our strategic alliance with MWE China Law Offices in Shanghai.
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM